What it is: AVIIR™ is a three-ingredient concentrated botanical antiviral and antimicrobial formula from Panaxea International, delivering three standardized isolates — Andrographis paniculata (standardized to 95% Andrographolide), Taraxacum officinale (standardized to 20% Taraxasterol), and Lonicera japonica (standardized to 25% Chlorogenic acid) — in a 500 mg vegetable capsule. Each ingredient is standardized to its primary bioactive at concentrations well above typical herbal extract thresholds. Manufactured to Australian Pharmaceutical GMP standards for exclusive practitioner-directed use.
How it works: Andrographolide (95% standardization) drives the formula's primary antiviral and antibacterial activity — inhibiting NF-κB-mediated inflammatory cytokine production, blocking viral replication through protease inhibition, and demonstrating activity against drug-resistant Gram-negative bacteria. Taraxasterol (20% standardization) delivers direct antiviral, hepatoprotective, and immunomodulatory activity through triterpene-mediated mechanisms — supporting liver detoxification of pathogenic burden and modulating innate immune responses. Chlorogenic acid from Lonicera japonica (25% standardization) provides complementary antiviral activity against influenza and respiratory viral pathogens through viral replication inhibition, alongside antibacterial, antipyretic, and anti-inflammatory activity through cyclooxygenase pathway modulation. Together the three standardized isolates address bacterial, viral, and fungal pathogen burden through overlapping and non-redundant mechanisms.
When to use it: Indicated for adults requiring broad-spectrum botanical antiviral, antibacterial, and immune support — including upper respiratory viral infections, persistent or drug-resistant bacterial infections, and seasonal immune challenges. Two to three capsules two to three times daily, or three capsules three times daily for one month in acute or persistent presentations. Contraindicated during pregnancy and breastfeeding.
Serving Size: 3 Capsules
Servings Per Container: 20
Suggested Use: As a dietary supplement, take 2–3 capsules 2–3 times daily, or as prescribed by your healthcare practitioner. For persistent concerns, take 3 capsules 3 times daily for one month.
|
Ingredient |
Amount Per Serving |
% Daily Value |
|
Andrographis paniculata (Chuan Xin Lian) (standardized to Andrographolide 95%) |
150 mg |
† |
|
Taraxacum officinalis (Pu Gong Ying) (standardized to Taraxasterol 20%) |
600 mg |
† |
|
Lonicera japonica (Jin Yin Hua) (standardized to Chlorogenic Acid 25%) |
600 mg |
† |
† Daily Value not established.
Other Ingredients: Vegetable cellulose (hypromellose), vegetable stearic acid, microcrystalline cellulose, vegetable magnesium stearate.
Does Not Contain: Wheat, gluten, soy, milk, eggs, fish, crustacean shellfish, tree nuts, peanuts.
Caution: Contraindicated during pregnancy and lactation. If you are taking any medications or have a medical condition, consult your healthcare practitioner before use. Do not use if you have known hypersensitivity to any of its ingredients. Do not use if tamper-evident seal is broken or missing. Keep out of reach of children. Store in a cool, dry place away from sunlight.
✓ Vegetarian ✓ Gluten Free ✓ Dairy Free ✓ Soy Free ✓ Egg Free ✓ Nut Free
Key Ingredients
Andrographis paniculata (standardized to Andrographolide 95%) — 150 mg Andrographis paniculata is standardized to 95% Andrographolide — one of the highest standardization thresholds available for this botanical — ensuring consistent delivery of the primary diterpene lactone responsible for its antiviral, antibacterial, antipyretic, and immunomodulatory activity. Andrographolide inhibits NF-κB nuclear translocation to suppress pro-inflammatory cytokine production, blocks viral protease and polymerase activity to inhibit replication across multiple viral species, and has demonstrated activity against drug-resistant Gram-negative bacteria including clinically relevant hospital-acquired strains. At 150 mg per serving standardized to 95%, this extract delivers the formula's primary direct antiviral and antibacterial mechanism alongside its most potent anti-inflammatory and immune-stimulating activity.
Taraxacum officinale (standardized to Taraxasterol 20%) — 600 mg Taraxacum officinale is delivered at the formula's highest dose — 600 mg per serving — standardized to 20% Taraxasterol, the primary pentacyclic triterpene responsible for its documented direct antiviral, hepatoprotective, immunomodulatory, and anti-inflammatory activity. Taraxasterol modulates innate immune cell activity, supports hepatic detoxification enzyme function, and exerts direct antiviral activity through inhibition of viral entry and replication mechanisms — providing the formula's primary hepatoprotective and immune-regulatory mechanism alongside Andrographolide's direct pathogen-targeting activity. At 600 mg it is the formula's dominant dose by a significant margin, reflecting Taraxasterol's role as the primary immunomodulatory and hepatoprotective anchor of the AVIIR™ formulation.
Lonicera japonica (standardized to Chlorogenic acid 25%) — 600 mg Lonicera japonica flower is standardized to 25% Chlorogenic acid — the primary phenolic acid responsible for its documented antiviral, antibacterial, antipyretic, and anti-inflammatory activity, and the compound recognized in the Chinese Pharmacopoeia as the quality marker for this botanical. Chlorogenic acid inhibits viral neuraminidase and replication enzymes with documented activity against influenza, SARS coronavirus, H1N1, and respiratory viral pathogens, while simultaneously exerting bacteriostatic activity and cyclooxygenase-mediated antipyretic and anti-inflammatory effects. It provides the formula's primary upper respiratory antiviral coverage — particularly relevant for influenza, viral URTI, and respiratory inflammatory burden — complementing Andrographolide's broad-spectrum antiviral and Taraxasterol's immune-regulatory activity.
